AptarGroup, Inc. Appoints Gael Touya as Director

On August 29, 2026, AptarGroup, Inc. announced an increase in its Board of Directors from ten to eleven members, with the appointment of Gael Touya, effective September 1, 2026. Mr. Touya will serve until the 2028 annual meeting of stockholders. He is not expected to join any board committees. Mr. Touya, who was previously President of the Aptar Pharma segment, assumed the role of President and Chief Executive Officer on September 1, 2026, succeeding Stephan B. Tanda. His appointment as director is not based on any agreements with other parties, nor does he have a familial relationship with any company officers or directors. He has no direct or indirect interest in any transactions requiring disclosure under Item 404(a) of Regulation S-K. As an employee, Mr. Touya will not receive additional compensation for his board service; his compensation as President and CEO was previously disclosed.